Pharmaceutical companies in the United States by one-year price change

How far the share price has moved over the last 52 weeks.

Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +387%, ahead of Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%). Figures as of 20 Nov 2026, 17:45 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
Erasca+387%
Median
+22.1%
Combined market value
£2.87T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
GBP
Clear filters
Pharmaceutical companies in the United States by one-year price change
#Company1 year ↓Market capPriceToday1 yearPrice, 30 daysCountry
1ErascaERAS · Health Care+387%£3.8B£10.72 1.27% down 387% up United States
2Spyre TherapeuticsSYRE · Health Care+302%£6.8B£72.10 3.26% down 302% up United States
3Oruka TherapeuticsORKA · Health Care+233%£4.9B£71.88 3.48% down 233% up United States
4VeradermicsMANE · Health Care+230%£3.9B£91.62 3.51% down 230% up United States
5Definium TherapeuticsDFTX · Health Care+176%£3B£22.23 1.22% down 176% up United States
6Dianthus TherapeuticsDNTH · Health Care+105%£3.6B£64.45 0.47% down 105% up United States
7TG TherapeuticsTGTX · Health Care+103%£7.5B£49.36 0.34% down 103% up United States
8ViatrisVTRS · Health Care+90.1%£17B£14.86 2.06% down 90% up United States
9Praxis Precision MedicinesPRAX · Health Care+83.1%£6.5B£233.43 1.64% down 83% up United States
10Edgewise TherapeuticsEWTX · Health Care+81.6%£3.4B£30.69 2.36% down 82% up United States
11Amneal PharmaceuticalsAMRX · Health Care+79.0%£5.6B£16.17 0.98% down 79% up United States
12Royalty PharmaRPRX · Health Care+74.0%£30B£52.24 1.06% up 74% up United States
13Protagonist TherapeuticsPTGX · Health Care+45.2%£6.1B£93.53 1.21% down 45% up United States
14Ligand PharmaceuticalsLGND · Health Care+44.0%£4.4B£220.52 0.68% up 44% up United States
15Travere TherapeuticsTVTX · Health Care+39.2%£3.5B£36.88 0.04% up 39% up United States
16Merck & CoMRK · Health Care+35.9%£253.1B£102.68 1.29% up 36% up United States
17Mirum PharmaceuticalsMIRM · Health Care+34.6%£4.9B£74.47 2.14% up 35% up United States
18Johnson & JohnsonJNJ · Health Care+31.0%£496.7B£206.34 1.19% up 31% up United States
19Eli LillyLLY · Health Care+27.5%£919.8B£1,032.61 0.12% up 28% up United States
20Bristol-Myers SquibbBMY · Health Care+26.1%£92.4B£45.19 1.47% up 26% up United States
21Belite BioBLTE · Health Care+25.3%£4B£98.57 14.49% down 25% up United States
22Regeneron PharmaceuticalsREGN · Health Care+22.2%£73B£705.56 0.21% up 22% up United States
23Vertex PharmaceuticalsVRTX · Health Care+22.0%£101.1B£398.76 0.33% up 22% up United States
24AbbVieABBV · Health Care+20.0%£388.9B£220.02 1.66% up 20% up United States
25Elanco Animal HealthELAN · Health Care+18.2%£9.8B£19.59 2.36% down 18% up United States
26United TherapeuticsUTHR · Health Care+17.7%£18.1B£424.66 0.50% down 18% up United States
27Rhythm PharmaceuticalsRYTM · Health Care+14.8%£6B£86.10 3.42% down 15% up United States
28BridgeBio PharmaBBIO · Health Care+14.8%£11.5B£58.97 1.18% down 15% up United States
29BioMarin PharmaceuticalBMRN · Health Care+12.3%£9B£46.34 1.16% down 12% up United States
30PfizerPFE · Health Care+9.98%£119.6B£20.99 0.16% down 10% up United States
31Arrowhead PharmaceuticalsARWR · Health Care+7.91%£4.6B£32.61 2.14% down 8% up United States
32Axsome TherapeuticsAXSM · Health Care-9.21%£5.3B£100.23 3.23% down 9% down United States
33Corcept TherapeuticsCORT · Health Care-15.9%£5.3B£48.73 1.75% down 16% down United States
34Abbott LaboratoriesABT · Health Care-18.9%£137.3B£79.29 0.01% up 19% down United States
35CytokineticsCYTK · Health Care-21.4%£5.5B£39.33 0.12% up 21% down United States
36Cogent BiosciencesCOGT · Health Care-24.5%£3.6B£20.65 2.50% down 25% down United States
37PTC TherapeuticsPTCT · Health Care-25.7%£3.7B£43.87 1.46% down 26% down United States
38InsmedINSM · Health Care-27.3%£24.3B£110.88 0.55% up 27% down United States
39Madrigal PharmaceuticalsMDGL · Health Care-27.6%£6.9B£296.55 2.08% down 28% down United States
40ZoetisZTS · Health Care-33.8%£24.8B£61.15 0.84% down 34% down United States
41Summit TherapeuticsSMMT · Health Care-34.7%£6.1B£7.62 5.58% down 35% down United States
42Legend BiotechLEGN · Health Care-42.8%£2.3B£11.71 4.75% down 43% down United States
43Ionis PharmaceuticalsIONS · Health Care-64.2%£3.5B£20.94 0.79% up 64% down United States
44Alnylam PharmaceuticalsALNY · Health Care-66.1%£15.2B£113.75 0.81% up 66% down United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7633 GBP).

Questions and answers

Which pharmaceutical companies in the United States rank first by one-year price change?

Erasca (+387%), Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 17:45 UTC.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by one-year price change.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of £2.87T as of 20 Nov 2026, 17:45 UTC.

What does ranking by one-year price change measure?

How far the share price has moved over the last 52 weeks.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change

Underlying data: Yahoo Finance; SEC EDGAR.